AKT1 and urinary bladder carcinoma: These results suggest that SHMT1 inhibits the AKT/FOXO3 A signaling pathway by promoting ATIC to promote the proliferation, invasion, and EMT of BC cells and reduce their apoptosis level, thereby promoting the malignant progression of bladder cancer.